Association of vascular and inflammatory markers with metabolic disorders in women with polycystic ovary syndrome
Vojnosanitetski pregled · 2019 · 76 (7) · 703-709
DOI: 10.2298/vsp170504158b ↗Kurz gefasst
Fachartikel in der Zeitschrift Vojnosanitetski pregled, 2019. Verfasst von Aleksandra Boshku und 2 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).
Abstract (Originalsprache)
Background/Aim. The prevalence of metabolic disorders, obesity and insulin resistance in women with polycystic ovary syndrome (PCOS) occur early in life and places this group at risk of cardiovascular disease. Hyperhomocysteinemia and increased C-reactive protein (CRP) activity have an effect on promoting atherosclerosis. This study was designed to evaluate whether high sensitivity (hs-CRP) and homocysteine (Hcy) are elevated in PCOS and to elucidate their possible relation to obesity, insulin resistance, or metabolic changes usually present in women suffering from PCOS.
Methods
Serum concentration of hs-CRP and plasma levels of Hcy were evaluated in 73 PCOS women and 43 healthy women, together with clinical, anthropometric and hormonal parameters.
Results
The mean of body mass index (BMI), waist circumference (WC), waist to hip ratio and mean concentration of luteinizing hormone (LH), testosterone, androstenedione, free androgen index, fasting insulin, homeostatic model assessment of insulin resistance (HOMA- IR), hs-CRP and Hcy were significantly higher in PCOS women compared to age-matched healthy women. There was a positive correlation between hs-CRP and BMI, WC, insulin, triglycerides (p < 0.001) and significant negative correlation with LH, sex hormone binding protein (SHGB), HOMA-IR, high density lipoprotein cholesterol (HDL-C) (p < 0.001). The Hcy concentration had a significant negative correlation with HDL-C level (p < 0.05). The present study demonstrated increased mean concentration of Hcy in hs-CRP women with PCOS.
Conclusion
Our results support the use of these biomarkers in the evaluation of potential risk for cardiovascular diseases and early prognosis and treatment implications.
Zitieren
APA
Boshku, A., Panova, D., & Ivanovska, B. (2019). Association of vascular and inflammatory markers with metabolic disorders in women with polycystic ovary syndrome. Vojnosanitetski pregled, 76(7), 703-709. https://doi.org/10.2298/vsp170504158b
Vancouver
Boshku A, Panova D, Ivanovska B. Association of vascular and inflammatory markers with metabolic disorders in women with polycystic ovary syndrome. Vojnosanitetski pregled. 2019;76(7):703-709. doi:10.2298/vsp170504158b
BibTeX
@article{Boshku2019,
author = {Boshku, Aleksandra and Panova, Daniela and Ivanovska, Beti},
title = {Association of vascular and inflammatory markers with metabolic disorders in women with polycystic ovary syndrome},
journal = {Vojnosanitetski pregled},
year = {2019},
volume = {76},
number = {7},
pages = {703--709},
doi = {10.2298/vsp170504158b}
}
EUVIMED